Feds And Marijuana Opponents Agree On Briefing Schedule In Lawsuit Challenging Trump’s Reclassification Move
DOJ and marijuana opponents agree on a briefing schedule in a lawsuit challenging federal cannabis rescheduling, impacti…
Read more →
GOP Congressman Says Marijuana Rescheduling Should Expand To ‘Across-The-Board’ Review Of Psychedelics And Other Drugs
GOP Rep. Brian Mast calls for expanding federal rescheduling efforts to include an across-the-board review of cannabis, …
Read more →Federal marijuana rescheduling means institutional capital is coming to cannabis investing
Federal marijuana rescheduling is bringing institutional capital to cannabis investing. Learn how Schedule III changes f…
Read more →Washington state to tweak cannabis rules to comply with federal marijuana rescheduling
Washington state regulators update cannabis rules to align with federal rescheduling, impacting local compliance and ope…
Read more →
Washington Officials Take Steps To Make It Easier For Medical Marijuana Businesses To Access Federal Rescheduling Benefits
Washington state creates a pathway for medical cannabis businesses to document operations, easing access to potential fe…
Read more →
Iowa Democratic Gubernatorial Candidate Praises Trump For Rescheduling Marijuana
Iowa Democratic gubernatorial nominee Rob Sand praises Trump administration marijuana rescheduling efforts, highlighting…
Read more →State officials push DEA for cannabis rescheduling guidance (Newsletter: October 8, 2026)
State officials urge DEA for rescheduling guidance as new polls show cannabis replacing alcohol. Stay updated on federal…
Read more →
It’s ‘High Time’ For DEA To Answer Questions About Marijuana Rescheduling, State Officials Say
State marijuana regulators demand answers from the DEA regarding federal cannabis rescheduling, creating uncertainty for…
Read more →Why are marijuana multistate operators supporting an anti-marijuana Senate candidate?
Explore why major cannabis multistate operators are funding political committees supporting anti-marijuana Senate candid…
Read more →
Federal Officials Say Marijuana Industry Tax Guidance Will Be A ‘Priority’ For The Next Year
Federal officials prioritize cannabis tax guidance following Schedule III rescheduling plans, signaling major financial …
Read more →
DEA Judge Puts Federal Cannabis Rescheduling Process on Pause
DEA judge pauses cannabis rescheduling hearings to review a GAO report highlighting procedural flaws at the DEA and FDA.
Read more →VA Would Be Required To Study Medical Marijuana’s Benefits For Veterans With PTSD And Pain Under New Congressional Bill
New bipartisan bill requires the VA to study medical cannabis for veterans with PTSD and chronic pain, signaling potenti…
Read more →New delay for federal marijuana rescheduling as flaws in process parsed
Federal marijuana rescheduling faces new delays as the DEA reviews procedural flaws, extending tax and regulatory uncert…
Read more →DEA judge grants cannabis opponents’ request to pause rescheduling hearing (Newsletter: September 30, 2026)
DEA judge pauses cannabis rescheduling hearings, delaying federal reform timelines. Get key updates on policy, state mar…
Read more →DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes
DEA judge pauses marijuana rescheduling hearings after a federal report highlights gaps in controlled substance evaluati…
Read more →DEA Should Coordinate With State Officials To Ensure Marijuana Rescheduling Is Successfully Implemented (Op-Ed)
DEA marijuana rescheduling requires state coordination to prevent operational disruptions. Learn what federal guidance m…
Read more →Mainstream insurance companies push for cannabis industry access
Mainstream insurers are pushing for legislative access to the cannabis industry, signaling potential relief on high comm…
Read more →Most Missouri cannabis operators opted out of DEA registration. Was it a mistake?
Two-thirds of Missouri cannabis operators skipped DEA registration after federal rescheduling. Read the business impact …
Read more →DEA keeps states in the dark about cannabis rescheduling, CA official says (Newsletter: September 22, 2026)
DEA keeps states in the dark on rescheduling as NC weighs state-run stores, IL advances equity payments, and PA holds le…
Read more →
DEA Hasn’t Shown ‘Any Sort Of Interest’ In Helping States Prepare For Marijuana Rescheduling, Top California Official Says
California regulators report zero DEA guidance on marijuana rescheduling, complicating compliance planning for cannabis …
Read more →
Alabama Health Officials Withdraw Objection to Rescheduling Medical Cannabis
Alabama health officials withdrew objections to federal cannabis rescheduling, signaling a shift in state regulatory att…
Read more →Cannabis & federal employment bill in Congress (Newsletter: September 21, 2026)
Track federal cannabis employment bills, rescheduling updates, and medical research impacting dispensary and brand opera…
Read more →
Alabama Officials Withdraw Objection To Rescheduling Marijuana Under State Law In Line With Trump’s Federal Move
Alabama health officials withdraw objections to rescheduling marijuana, aligning state policy with federal shifts and im…
Read more →Alabama drops opposition to federal marijuana rescheduling
Alabama drops opposition to federal marijuana rescheduling as state health officials resolve legal concerns, signaling a…
Read more →How the fight to save adult-use cannabis in Massachusetts could save marijuana rescheduling – and beyond
Mass. cannabis repeal efforts threaten national legalization. Industry leaders must watch this fight's impact on federal…
Read more →
DEA Is Taking On The Role Of Marijuana Regulator Under Trump’s Rescheduling Move (Op-Ed)
Federal marijuana rescheduling shifts oversight to the DEA, bringing new compliance challenges and stricter federal regu…
Read more →
New Congressional Bill Could Boost Development Of Plant-Based Medicines, Including Those Derived From Cannabis Or Psychedelics
New congressional bill aims to boost R&D for plant-based medicines including cannabis and psychedelics, impacting federa…
Read more →
FDA Psychedelics Hearing Focuses On Boosting Therapeutic Innovations While Adhering To Scientific Standards
FDA hearing on psychedelic therapy highlights federal regulatory priorities around scientific standards, offering strate…
Read more →
There Will Be ‘Enormous Demand’ For Psychedelic Treatments, RFK Says, Praising Trump’s Action On The Issue
HHS Secretary RFK Jr. predicts massive demand for psychedelic therapies under Trump, signaling potential shifts for the …
Read more →Marijuana Dispensary Owner Says DEA Is Forcing Her To Fire Workers In Order To Get Federal Protections Under Trump’s Rescheduling Move
Mississippi dispensary owner fights DEA rules requiring worker termination for federal rescheduling protections, impacti…
Read more →